UK markets closed
NIKKEI 225
27,402.05 +55.17 (+0.20%) HANG SENG
21,958.36 -113.82 (-0.52%) CRUDE OIL
76.75 +0.34 (+0.44%) GOLD FUTURES
1,927.10 -15.70 (-0.81%) DOW
33,990.33 -102.63 (-0.30%) BTC-GBP
19,604.51 +740.80 (+3.93%)
BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:19PM EST. Market open.
| Previous close | 143.05 |
| Open | 142.64 |
| Bid | 144.34 x 1100 |
| Ask | 144.60 x 900 |
| Day's range | 141.83 - 144.97 |
| 52-week range | 117.08 - 189.07 |
| Volume | |
| Avg. volume | 966,134 |
| Market cap | 34.905B |
| Beta (5Y monthly) | 0.26 |
| PE ratio (TTM) | 3.39 |
| EPS (TTM) | 42.47 |
| Earnings date | 27 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Jun 2022 |
| 1y target est | 208.90 |
- Globe Newswire
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
Plasmids are an important starting material for the manufacturing of mRNA- and cell-based drugsThe new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing an important starting material for its oncology and COVID-19 vaccine pipeline The investment of approximately €40 million is part of a long-term development plan for BioNTech’s manufacturing site in Marburg German Chancellor Olaf Scholz is visiting the facility together with BioNTech co-founders
- Simply Wall St.
Analysts Just Slashed Their BioNTech SE (NASDAQ:BNTX) EPS Numbers
Today is shaping up negative for BioNTech SE ( NASDAQ:BNTX ) shareholders, with the analysts delivering a substantial...
- Zacks
The Zacks Analyst Blog Highlights Pfizer/BioNTech, Moderna and Novavax
Pfizer/BioNTech, Moderna and Novavax are included in this Analyst Blog.
© 2023 Yahoo. All rights reserved.
